Amended Complaint Merges Medicis Investors' Claims
A legal battle launched against Medicis Pharmaceutical Corp. last year has expanded with the filing of a consolidated amended complaint, which merges proposed class action claims from a slew of investors...To view the full article, register now.
Already a subscriber? Click here to view full article